The Limited Times

Now you can see non-English news...

Race for corona vaccine: nine candidates in a crucial phase

2020-09-16T14:44:43.219Z


Researchers around the world are racing to get a vaccine against the coronavirus. Nine candidates are already in the crucial phase.


Researchers around the world are racing to get a vaccine against the coronavirus.

Nine candidates are already in the crucial phase.

  • All over the

    world

    , a

    vaccine

    against the coronavirus *

    researched.

  • Nine

    candidates

    from international

    companies

    and

    research institutes

    are currently in the crucial

    test phase

    .

  • However

    , there are also

    inconsistencies

    with some potential

    vaccines

    against

    Covid-19

    .

Berlin - Both in terms of

containment of

the rampant coronavirus * and the development of a

vaccine

against

Covid-19

,

Germany

stands up

well in international comparison.

Despite the currently increasing number of cases, the currently falling R value gives hope *.

Nevertheless: A second wave could threaten here too *.

The

RKI

expects that there will be several different vaccines * in Germany.

But not only in

Germany

is currently working flat out on a vaccine against the novel coronavirus *.

The

competition

from the international laboratories

not sleeping.

According to the WHO, a serum against

Covid-19 is being

sought

in 176 projects worldwide

.

Nine of these potential

vaccines

are currently

in the third and decisive test phase, in which the agent will be tested on tens of thousands of volunteers.

In some

countries

, parts of the

population are

even vaccinated,

according to their

governments

.

Coronavirus vaccine - these candidates are in the third phase of testing:

Company / research institute

country

University of Oxford / AstraZeneca

Great Britain / Sweden

CanSino Biological Inc./Beijing Institute of Biotechnology

China

Gamaleya Research Institute

Russia

Janssen Pharmaceutical Companies

Belgium

Sinovac

China

Wuhan Institute of Biological Products / Sinopharm

China

Beijing Institute of Biological Products / Sinopharm

China

Moderna / NIAID

United States

BioNTech / Pfizer

USA / Germany

USA: positive developments - vaccine against coronavirus in "three or four weeks"

"We are about to have a vaccine," said

Donald Trump

on Tuesday evening on the US TV channel

ABC News

.

More precisely, the

US President

spoke

of "three or four weeks" in which one could have a

vaccine

against the

coronavirus

.

Health experts

and politicians in the

USA

criticize the fact that the elections on November 3rd of this year would put political pressure on the US drug

regulatory authority FDA

.

“A vaccination has to be safe, effective and trustworthy,” Caitlin Rivers wrote in advance on Twitter.

The epidemiologist at the University of Johns Hopkins in Baltimore said that

the

coronavirus

vaccine

must meet

all three criteria

: "It would be a tragedy if politicians, for political reasons, jeopardized the one thing that could allow us, ours return to normal life ”.

A vaccine must be safe, effective and trusted.

It's not a “pick 2” situation - we need all three.

It would be a tragedy if leaders jeopardized the thing that may allow us to safely return to our way of life for political expedience.

- Caitlin Rivers, PhD (@cmyeaton) August 22, 2020

The US pharmaceutical

company Pfizer

, which is working together with the Mainz-based company

Biontech

on a

serum

against the

coronavirus

, was meanwhile able to

celebrate its

first successes in the third

test phase

.

As the

ARD

reports, the

FDA has

now

promised

that the number of participants in the tests could be increased from 30,000 to 44,000 subjects.

If the results are positive, Pfizer and Biontech could

apply for

approval of the

vaccine

against the

coronavirus

as early as October

.

Russia: first approved vaccine against coronavirus - doubts about the veracity of the studies

+

Research is being carried out around the world for a vaccine against the coronavirus.

© Ted S. Warren / dpa

Russia

was the first country in the world that had approved a vaccine against the coronavirus in an urgent manner and is

already

vaccinating parts of the

population

- despite international concerns.

The third

phase of the study

on the

efficacy

and tolerability of

Sputnik-V

was not carried out prior to approval.

That caused a lot of criticism - experts even warned against the Russian vaccine against Covid-19.

As evidence of the effectiveness of

Sputnik-V

, the Russian

scientists

published

data on the

vaccine

against the

coronavirus

in the specialist journal

Lancet

at the beginning of September

.

However, some international

researchers

are

now questioning

the authenticity of these values ​​and suspecting

Russia

of

manipulation

.

Upon closer inspection of the results, the experts

noticed

several

inconsistencies

, as reported by the

Frankfurter Rundschau

*.

China: First vaccinations against the coronavirus - open to the public in a few months

China

is represented with many candidates in the international race for a

vaccine

against the

coronavirus

, some of which are already

completing

the third

study test phase

.

In this context, there has already been international criticism due to allegedly outrageous methods.

According to the government,

soldiers are

already being

vaccinated

against

Covid-19

with a potential

serum

from the Institute of the People's Liberation Army

.

The development of a

vaccine

against the

coronavirus is

going "very smoothly", as an

epidemiologist from 

the Center for

Disease Control

and Prevention

told

the Chinese TV broadcaster

CCTV

on Monday evening.

According to her, the serum could be made available to the public "around November or December".

However

, the epidemiologist did not disclose

which of the many Chinese

vaccine candidates

it is.

Great Britain / Sweden: Third test phase of vaccine against coronavirus continues

AstraZeneca

is also

a bearer of hope in the search for a

vaccine

against the

coronavirus

.

The Swedish-British pharmaceutical company recently suffered a major setback.

Last week, the

tests in

the third

phase of the study

had to be stopped - a test person is said to have contracted a rare neurological disease.

When the

test was stopped

, however, it was presumably a routine measure.

After a few days, the authorities confirmed that the disease was not due to the potential

vaccine

against the

coronavirus

.

The study by AstraZeneca is therefore now being continued.

(als) * Frankfurter Rundschau and Merkur.de is part of the nationwide Ippen digital editorial network.

List of rubric lists: © Ted S. Warren / dpa

Source: merkur

All news articles on 2020-09-16

You may like

News/Politics 2024-03-18T14:18:09.201Z
News/Politics 2024-03-16T18:46:42.470Z

Trends 24h

News/Politics 2024-04-18T11:17:37.535Z
News/Politics 2024-04-18T20:25:41.926Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.